Ascletis Pharma Inc. (FRA:2VJ)
1.320
-0.040 (-2.94%)
Last updated: Dec 22, 2025, 8:59 AM CET
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of €1.41 billion as of December 22, 2025. Its market cap has increased by 684.12% in one year.
Market Cap
1.41B
Enterprise Value
1.20B
Revenue
280.99K
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.32
Market Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has decreased from 1.71B to 1.41B, a decrease of -17.45%. That is a compound annual growth rate of -2.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 1.41B | 291.61% |
| Dec 31, 2024 | 361.09M | 104.81% |
| Dec 29, 2023 | 176.31M | -71.49% |
| Dec 30, 2022 | 618.38M | 53.38% |
| Dec 31, 2021 | 403.17M | 21.25% |
| Dec 31, 2020 | 332.50M | -11.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 130.23B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |